Table 1. Declined human kidney characteristics and experimental conditions.

Donor demographics, donor type; donation after brain death (DBD), donation after circulatory death (DCD), reason for decline, warm ischemic time, cold ischemic time, duration of ex vivo normothermic perfusion (NMP), mean renal blood flow (RBF), total urine output, macroscopic appearance, NPs, and time to administration of NPs.

	Case 1	Case 2	Case 3	Case 4	Case 5	Case 6	Case 7	Case 8
Donor age (years)	57	25	44	68	45	64	65	57
Donor type (DBD/DCD)	DCD	DBD	DCD	DBD	DBD	DCD	DCD	DCD
Left/right kidney	Left	Right	Right	Right	Left	Left	Left	Left
Reason for decline	Poor in situ perfusion	Malignancy	Suspected malignancy	Suspected malignancy	Poor in situ perfusion + prolonged agonal phase	Suspected malignancy	Histological changes consistent with diabetes	Damage to ureter and artery
Warm ischemic time (min)	13	—	13	—	—	12	14	11
Cold ischemic time (hour:min)	13:13	17:17	34:37	16:03	22:38	27:05	18:20	25:58
NMP duration (hour:min)	4:30	6:50	5:45	5:00	5:00	8:30	8:30	8:30
Mean RBF (ml/min per 100 g)	88.0 ± 19.6	123.7 ± 35.2	91.6 ± 23.9	67.9 ± 31.7	83.5 ± 35.5	75.0 ± 22.1	77.3 ± 25.4	80.7 ± 37.7
Total urine output (ml)	177	730	107	1045	373	598	451	257
Macroscopic appearance	Moderate	Moderate	Moderate	Moderate	Moderate	Excellent	Excellent	Moderate
NP type	CD31-NP	Control-NP	CD31-NP + Control-NP	CD31-NP + Control-NP	CD31-NP + Control-NP	CD31-NP + Control-NP	CD31-NP + Control-NP	CD31-NP + Control-NP
NP circulating concentration	4 μg/ml	4 μg/ml	10 μg/ml	50 μg/ml	100 μg/ml	50 μg/ml	50 μg/ml	50 μg/ml
NP administration time (from start of perfusion)	30 min	50 min	45 min	75 min	60 min	30 min	30 min	30 min